A recent NBC News article discussed Pfizer’s plans to submit data to the FDA for a fourth dose of its COVID-19 vaccine. As Pfizer CEO Albert Bourla put it to CNBC in an interview last Friday, “Clearly there is a need in an environment of omicron to boost the immune response.” Pfizer’s scientists are seeing that the initial booster’s protection against omicron is beginning to wane after three to four months, suggesting a need for a fourth dose.
Pfizer Nears Submitting Data to FDA for 4th COVID-19 Shot
Omicron-related cases are down significantly, but certain groups may still need additional vaccine protection.
Mar 17, 2022
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
